The single greatest change to affect the UK fertility sector in nearly two decades will take place tomorrow, Thursday 1 October, as the new Human Fertilisation and Embryology Act 1990 (as amended) comes into force. Changes which will come into effect with the new legislation include: * increasing the length of time people can store their embryos * a ‘cooling off’ period if one partner withdraws consent for embryo storage * extending information access rights for donor conceived people and donors * opening the Human Fertilisation and Embryology Authority’s (HFEA) Register for research * introducing supportive parenting into the welfare of the child provisions * banning sex selection for non medical reasons * clarifying the scope of embryo research
BERLIN — Embryos created during in vitro fertilization can be screened for genetic defects before being implanted in the womb, a German high court said in a landmark ruling Tuesday. The Federal Supreme Court in Leipzig ruled in support of a Berlin gynecologist who had carried out screening on embryos for three different couples and implanted only those that were healthy. The embryos with hereditary genetic defects were left to die off. The high court's ruling upheld a decision by a Berlin state court that the doctor's action did not violate German laws for the protection of embryos. The 47-year-old doctor, who was not identified by the court, brought the case to court himself in 2006 to clarify the legal situation. He was first acquitted by a regional court in Berlin, but the city's state prosecutor appealed.
Should the UK Human Fertilisation and Embryology Authority (HFEA) be rescued from the axe, or should it, as the UK government proposes, be allowed to perish, its functions absorbed by larger, more general bodies? At a panel discussion organised by the Progress Educational Trust at the Royal Society in central London, three of the four speakers favoured retaining a specialist regulator of infertility treatment and embryo research. But Alison Murdoch, professor of reproductive medicine at Newcastle University’s Institute of Human Genetics, disagreed and called for an independent review of the HFEA’s function in regulating treatment.